Similar articles

• Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia.

  Sanchez-Larsen A, Sopelana D, Diaz-Maroto I, Perona-Moratalla AB, Gracia-Gil J, García-Muñozguren S, Palazón-García E, Segura T. Sanchez-Larsen A, et al. Eur J Pain. 2018 Jul;22(6):1080-1087. doi: 10.1002/ejp.1192. Epub 2018 Feb 12. Eur J Pain. 2018. PMID: 29369456
• Trial of carbazepine (tegretol) in trigeminal neuralgia.

  Janaki S, Sehgal AD, Kothari HS. Janaki S, et al. Neurol India. 1968 Jan-Mar;16(1):17-9. Neurol India. 1968. PMID: 5681712 No abstract available.
• [Anti-epileptic drugs in the treatment of essential trigeminal neuralgia].

  Bergouignan M. Bergouignan M. Presse Med (1893). 1970 Oct 10;78(42):1832-4. Presse Med (1893). 1970. PMID: 5506788 French. No abstract available.
• Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: Evidence and experience.

  Alcántara Montero A, Sánchez Carnerero CI. Alcántara Montero A, et al. Neurologia (Engl Ed). 2019 Jul-Aug;34(6):386-395. doi: 10.1016/j.nrl.2016.11.009. Epub 2017 Feb 16. Neurologia (Engl Ed). 2019. PMID: 28215909 Review. English, Spanish.
• Review article: the medical management of trigeminal neuralgia.

  Green MW, Selman JE. Green MW, et al. Headache. 1991 Oct;31(9):588-92. doi: 10.1111/j.1526-4610.1991.hed3109588.x. Headache. 1991. PMID: 1774173 Review.